The global intraoperative radiation therapy (IORT) market is poised for substantial growth, expected to achieve a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2022 to ...

This publication provides an updated source for professionals involved in employing guided intraoperative scintigraphic tumour targeting (GOSTT). Its content contributes to supporting both the ...

THURSDAY, March 6, 2025 (HealthDay News) -- For patients undergoing elective surgery, intraoperative use of remifentanil and sufentanil is independently associated with a poorer postoperative pain ...

The FDA has granted 501(k) clearance to ZEISS INTRABEAM 700, a robotic-assisted platform designed to enhance intraoperative ...

The FDA has granted approval for Innoblative Designs' IDE application, allowing it to commence a feasibility study in the US.

Zeiss Medical Technology announced today that it received FDA 510(k) clearance for the Intrabeam 700 platform.

Proprio’s AI surgical guidance platform, Paradigm receives US FDA 510(k) clearance: Seattle Friday, April 11, 2025, 14:00 Hrs [IST] Proprio, the global leader in AI-powered surg ...

Surgical technology company Proprio earned its second major FDA 510(k) clearance to include intraoperative measurements for ...

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro ...